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ABSTRACT
Stroke like migraine attacks after radiotherapy (SMART) syndrome is a phenomenon of reversible neurologic 
dysfunction which occurs rarely years after radiotherapy for brain tumors. We present a 35years old patient who had 
new onset neurological dysfunction with fits twice in between a symptom free interval of one year. He had radiotherapy 
for grade 1 astrocytoma about 27 years ago. Tumor recurrence or growth was ruled out both times by neuroimaging. 
Alternate diagnosis like meningoencephalitis were also ruled out by appropriate workup. Patient was managed on 
antiepileptics and antiplatelets. Radiation induced vasculopathy was an important differential. The mechanism of both 
SMART and radiation induced vasculopathy appears similar. Having knowledge of such rare but important conditions 
is important for neurologist as it can save patients from unnecessary investigations.
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C A S E  R E P O R T
INTRODUCTION
Stroke-like migraine attacks after radiation therapy 
(SMART) is an extremely rare delayed complication of 
brain irradiation.  Patients suffer from recurrent 
episodes of complicated migraine symptoms, 
consisting of transient neurologic deficits such as 
hemiparesis, aphasia, and sensory disturbances. 42 
cases of SMART have been reported in the literature 
since it was first described in 1995.1
We present a case of young male who had episodes of 
recurrent neurological dysfunction with seizures.
CASE REPORT
A 35yearmale who had history of astrocytoma (grade 1) 
brain diagnosed about 27 years ago when he was only 
8 years old. He had about 60 cycles of radiotherapy 
following tumor removal. The patient recovered well 
and was independent with activities of daily living for 
the next 25 years. He had an episode of sudden onset 
right sided weakness with dysarthria and fits two years 
ago. His MRI brain ruled out any tumor recurrence. He 
was started on dual antiplatelets, high dose statins. 
and was continued on antiepileptics and symptoms 
resolved. 
He had no risk factors for ischemic stroke and he was 
thoroughly investigated for young stroke.MRI brain also 
showed large area of gliosis in left frontoparietal region 
as shown in figure 1.
Figure 1. MRI brain showing large area of gliosis in left 
frontoparietal region (arrow) and left cortical atrophy.
After about a year and a half he had another episode of 
headache, photo phobia,along with dysphasia and new 
onset right sided weakness. Headache was throbbing 
and lasted for a day before development of right sided 
symptoms.He also had transient episodes of vacant 
spells which were treated as seizure,antiepileptics were 
increased and such spells were controlled. CSF routine 
examination and opening pressure was normal. EEG did 
not show any epileptiform discharges.MRI brain with 
contrast again ruled out tumor recurrence and 
1 8P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S V O L .  1 3  ( 3 )   J U LY- S E P T E M B E R  2 0 1 8
1 9P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S
leptomeningeal disease. MRI brain DWI sequence 
showed subacute infarcts in left parietal parasagittal 
and parasylvian region as shown in figure 2.
Figure 2. MRI brain DWI sequence (Right) showing 
area of restricted diffusion left parasylvian 
region(arrow).MRA brain (left)showed attenuated left 
ICA(arrow) and severely attenuated and thrombosed 
left MCA.
MRA brain showed attenuated left ICA and attenuated 
and thrombosed left MCA as shown in figure 2 left). 
Patient was thoroughly worked up for thrombophilia, 
His protein C, S, factor laiden, antithrombin III were 
negative. His ANA and vasculitis profile was 
negative.ECG, echocardiogram and 24 hours holter 
monitoring was also normal. Patient was started on 
dual antiplatelets and symptoms gradually improved 
but residual right sided weakness persisted this time.
DISCUSSION
When tumor recurrence has been ruled out in a patient 
with brain tumor treated with surgery and radiotherapy 
who presents with neurological symptoms, 
complications of radiation therapy such as progressive 
leukoencephalopathy with cognitive decline, focal 
radiation necrosis mimicking recurrent tumor as well as 
SMART should be considered.2
The clinical and radiological picture of this patient is 
compatible with the SMART syndrome. SMART 
syndrome involves transient, reversible neurological 
dysfunction which may include migrainous headache, 
at times preceded by aura, prolonged hemispheric 
neurological impairment and sometimes seizure 
activity1like our patient had headache, focal right sided 
weakness and aura like visual symptoms.His symptoms 
resolved after first episode but after second episode 
they were considered to be due to radiation induced 
vasculopathy as confirmed by MRA changes.
Neuroimaging studies of patients with SMART 
syndrome typically show focal gyral thickening of the 
affected cortex and gyriform contrast enhancement2.
The clinical presentation of SMART has similarities with 
PRES (posterior reversible encephalopathy syndrome), 
including headaches, neurological deficits and seizures 
are seen more frequently in PRES than in SMART. The 
pathophysiology of PRES is combined vasoconstriction 
and vasodilation and has the same patterns as seen in 
vasculopathy. This results in blood brain barrier 
disruption leading to symmetric hemispheric edema 
and contrast enhancement on MRI.3
Since radiation may preferentially damage endothelial 
cells, the SMART syndrome might be a reversible 
radiation vasculopathy comparable with PRES. An 
alternative hypothesis is that post-radiation neuronal 
dysfunction is the underlying mechanism, such as in 
migraine or epilepsy, with impairment of the 
trigeminovascular system or a lowered threshold for 
cortical spreading depression.2
Radiation to the brain and neck can induce a delayed 
vasculopathy with accelerated atherosclerosis which 
increases the risk of stroke, but this increased risk also 
manifests years after the radiotherapy.4 It is therefore 
difficult to differentiate between SMART and radiation 
induced vasculopathy. SMART episodes are generally 
considered reversible while vasculopathy is usually 
irreversible, but there have been few case series 
suggesting that SMART may be irreversible5. Our 
patient second episode of symptoms was also not 
reversible and was left with residual weakness.
Although SMART syndrome is an extremely rare 
condition, improvements in cancer survival rates have 
likely resulted in a rise in its frequency as probably 
previously patients did not survive long enough to see 
such late effects of these treatments and this entity 
was probably unrecognized. The interval in years 
between radiotherapy and the diagnosis of SMART 
ranges from 1 to 35 years. There does not appear to be 
an association between SMART and a particular tumor 
type.5
SMART is an extremely rare delayed complication of 
brain irradiation but awareness and recognition of this 
disorder are important to make a rapid diagnosis and 
avoid aggressive interventions such as brain biopsy or 
cerebral angiography. Further studies are needed to 
determine the exact etiology of this disorder, its 
mechanism of pathogenesis, potential biomarkers, its 
treatment and also how to avoid such complications 
especially when post radiation survival is greater.
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